After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden ...

Patients with diabetic macular edema (DME) maintained improvements in visual acuity and retinal anatomy for up to 4 years ...

A bioresorbable hydrogel implant enabled continuous intraocular delivery of axitinib, a small-molecule VEGFR TKI, positioning TKIs as a potential alternative to repeated anti-VEGF intravitreal ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of the EyeGility™ Inserter ...

Learn about teprotumumab for moderate to severe thyroid eye disease, its benefits, risks, as well as evolving treatment ...

China: A new treatment approach for diabetic macular edema (DME), combining an initial intravitreal anti-vascular endothelial ...

Trial met both co-primary endpoints of mean change from baseline in BCVA letter score and mean change from baseline CST with statistical ...

The first half of 2026 brought a steady drumbeat of regulatory and clinical news across the diabetic eye disease space, from ...

Cascade Prodrug and Uneedle are partnering to test suprachoroidal delivery of CPD100 using Uneedle's Bella-Vue microneedle system for the treatment of wet AMD. Cascade Prodrug and Uneedle are ...

IRX-101 targets a significant need for millions of patients facing vision loss and has the potential to improve the standard ...

The Eye Bleeds Before You Know It Diabetes does not attack the eye the way an infection does, with pain, redness, and urgency ...

Diabetes is often associated with complications such as heart disease, kidney damage, and nerve problems. However, one of its most serious yet frequently overl ...